mshealthcare > Anti_cancer > Vaccine

Category: Vaccine

Vaccines are essential medical products designed to protect individuals from infectious diseases by strengthening the body’s immune system. They work by stimulating the immune response to recognize and fight harmful pathogens such as viruses and bacteria, helping prevent illness, complications, and the spread of disease.
Vaccination plays a crucial role in public health by reducing the incidence of serious infections and controlling outbreaks. From childhood immunizations to adult and travel vaccines, these preventive solutions are recommended across all age groups to ensure long-term health and immunity.
This category includes a wide range of vaccines for various conditions, such as influenza, hepatitis, pneumococcal infections, HPV, and more. Common examples include Influvac Tetra for seasonal flu protection and Pneumovax 23 for protection against pneumococcal diseases.
All vaccines should be administered by qualified healthcare professionals following recommended schedules and guidelines. Staying up to date with vaccinations is one of the most effective ways to safeguard individual and community health

Posted on:

UNDERSTANDING BORTEZOMIB THERAPY WITH BORVIZ 2 mg

WHAT IS BORVIZ 2 MG?

Borviz 2 MG injection is a chemotherapy medication classified as a protease inhibitor, contains the active ingredient Bortezomib . it is prescribed for the treatment of multiple myeloma,a cancer of plasma cells in the bone marrow ,and mantle cell lymphoma, a less common cancer affecting the lymph nodes. It is an anti neoplastic agent that interferes with the growth of cancer cells ,which are eventually destroyed by the body.

DRUG CLASSIFICATION:

  •  Action class: proteasome inhibitors
  • Therapeutic class : anti-neoplastic /targeted therapy
  •  Chemical class: phenylalanine derivative
  •  Active ingredient: Bortezomib
  •  Usage: use in the treatment of multiple myeloma and mantle cell lymphoma
  •  Administration: intravenous or subcutaneous injection by a healthcare professional.

It is a cytotoxic agent primarily used for managing blood cancers, particularly when stem cell transplantation is not suitable.

WHAT ARE THE MEDICAL USES OF BORVIZ 2 MG INJECTION?

Borviz 2 mg injection contains Bortezomib, a protea some inhibitor used to treat adults with multiple myeloma (bone marrow cancer) and mantle cell lymphoma (a type of blood cancer affecting lymph nodes) . it acts by blocking protein breakdown in cancer cells, forcing them to die ,and is often used in combination therapy.

Some of the medical uses of Borviz 2 mg injection are:

1. Treatment of multiple myeloma

      Borviz 2 mg injection is a targeted cancer therapy used to treat multiple myeloma-a bone marrow cancer-by inhibiting protectorates to induce cancer cell death. It is administered by a healthcare professional ,often in combination with other medicine for both newly diagnosed and previously treated patients.

  •  Indications: used for treating multiple myeloma and mantle cell lymphoma. It is utilized in induction therapy before stem cell transplants for patients who cannot undergo a transplant.
  •  Mechanism of action: As a protease inhibitor, it interferes with the degradation of intercelluar proteins, causing an accumulation that leads to cancer cell death.
  •  Administered: it is given by intravenous (IV) or subcutaneous (under the skin) injection by a doctor.
  • Common side effects : low platelet count, peripheral nephropathy ,nausea, vomiting ,fatigue , constipation and fever.
  •  Precautions: requires monitoring of blood counts and organ function . it is not recommended during pregnancy or breastfeeding.
  • Management : patients are often advised to stay hydrated and avoid driving if they feel dizzy or tired.

2. Treatment of mantle cell lymphoma

 Borviz 2 mg injection is a targeted therapy used to treat mantal cell lymphoma (MCL) ,specifically in patients who have not responded to or have relapsed after other therapies. As a proteasome inhibitor, it destroys cancer cells and is often combined with rituximab and chemotherapy administered by a healthcare professional.

  •  Mechanism: it act as a protoseome inhibitor,interfering with the proteosonmes in cancer cells, which leads to their death and stops further growth.
  • Administration: it is administered either intravenously (in to the vein) or subcutaneously (under the skin) by a qualified healthcare professional.
  • Combination therapy : in MCL treatment, Borviz is often used in combination with other chemotherapy agents and rituximab, particularly for patients not suitable for stem cell transplantation.
  • Common side effects: common side effects include nausea, vomiting, diarrhea, peripheral neuropathy ,constipation etc.
  •  Precautions: it is not recommended during pregnancy or breastfeeding . it may cause dizziness, so caution is advised when driving.

3. Used as a part of combination chemotherapy regime

Borviz 2 mg injection is a protea some inhibitor used in chemotherapy to treat multiple myeloma and mantle cell by inducing cancer cell death. It acts by blocking protein degradation, causing stress that kills malignant cells. It is often used in combination with other agents like dexamethasone or thalidomide.

  • Multiple myeloma: used for treating myeloma, especially in patients who have not received prior treatment and are ineligible for blood stem cell transplantation.
  • Mantle cell lymphoma: used for patients with this type of non-hodgkins lymphoma who have received at least one prior therapy.
  •  Mechanism: as a protesome inhibitor, it breaks down essential protein in cancer cells, forcing them to undergo apoptosis .

WHAT ARE THE BENEFITS OF BORVIZ 2 MG INJECTION?

 

Benefits of Borviz 2 mg injection are:

1. Helps slows the growth of cancer cells

   Borviz 2mg injection, containing the active ingredient Bortezomib, is a protesome inhibitor used to treat multiple myeloma and mantle-cell lymphoma by slowing cancer cell growth and promoting their death. It works by interfering with proteosomes to induce apoptosis in cancer cells. It is primarily used for multiple myeloma and mantle cell lymphoma. As a protosome inhibitor, it interrupts the normal degradation of proteins within cancer cells, causing a toxic buildup that leads to cell death.

2. Improves treatment outcomes in multiple myeloma

       Borviz 2 mg injection ,which contains Bortezomib as its active ingredient, is a highly effective ,FDA approved proteasome inhibitor used to treat multiple myeloma and mantle -cell lymphoma. It significantly improves treatment outcomes by halting the progression of cancer cells, increasing survival rates and inducing deep responses in both newly diagnosed and refectory patients. As a proteasome inhibitor, it disrupts the 26s proteosome in cancer cells, leading to an accumulation of toxic proteins,which causes the cancer cells to undergo apoptosis.

3. May be combined with other cancer medicines for better results

  Borviz 2 mg is frequently combined with other medications like dexamethasone, melphalan, prednisone or rituximab to enhance efficiency . the treatment is administered by a professional ,often resulting in better outcomes than single agent therapy. It is often combined with dexamethasone, or with melphalan and prednisone. It is commonly combined with rituximab and other chemotherapy drugs. They are used with dexamethonase and thalidomide prior to stem cell transplantation.

      CONCLUSION: Bortezomib therapy is a highly effective, standard of care proteasome inhibitor for treating multiple myeloma and mantle cell lymphoma ,significantly improving patient survival rates. Subcutaneous administration is preferred for better tolerabilty, with manageable side effects like peripheral nephropathy and thrombocytopenia making it a cornerstone treatment for both newly diagnosed and relapsed patients.

FREQUENTLY ASKED QUESTIONS(FAQ)

QUESTION: IS BORVIZ A CHEMOTHERAPY DRUG?

Borviz is a targeted chemotherapy injection used to treat multiple myeloma and mantle-cell lymphoma by stopping cancer cell growth. it is important to maintain hydration during treatment and inform doctors of any pre-existing liver, kidney or heart conditions.

QUESTION: HOW MANY TREATMENT CYCLES ARE REQUIRED?

Treatment is administered in cycles, with the number of cycles depending on whether the cancer is newly diagnosed or relapsed. Generally several cycles are recommended, which may be adjusted based on the patient’s response to treatment. Treatment typically involves a series of cycles, often continuing based on clinical response.

QUESTION: CAN IT CURE MULTIPLE MYELOMA?

Borviz is a potentproteasome inhibitor used to treat multiple myeloma by inhibiting the growth of cancer cells, often leading to remission or significantly slowed disease progression. While it is not considered a permanent cure, it is highly effective in

managing newly diagnosed and relapsed cases.

REFRENCES

1.https://health29.in/item/borviz-2mg-injection-lyophilized-borviz%202mg%20injection%20%28lyophilized%29

2.https://www.apothecare.in/products/borviz-2mg-injection

3. https://www.tradeindia.com/products/borviz-2mg-inj-c7933103.html

Posted on:

EVERYTHING YOU NEED TO KNOW ABOUT AZADIN 100ML VIAL


Azadin (Azacitidine ) 100mg injection is a prescription chemotherapy medicine used to treat blood and bone marrow cancers ,specifically myelodysplastic syndromes(MDS) , acute myeloid leukemia (AML) and chronic myelomoocytic leukaemia (CCML) . it acts as an anti neoplastic agent that kills or stops the growth of cancer cells.

HOW IMPORTANT ARE CHEMOTHERAPY AND OTHER Targeted TREATMENTS IN BLOOD CANCER?
Chemotherapy and targeted treatments are cornerstone therapies for blood cancers (leukemia, lymphoma,myeloma) designed to systematically eliminate rapidly dividing cancer cells throughout the body, often achieving remission rates. While chemotherapy acts broadly to kill cancer cells, targeted therapies focus on specific genetic mutations or proteins, offering more precise treatment with fewer side effects and quality of life.

Importance of chemotherapy in blood cancer
l Systematic treatment : Because blood cancer are not localized to one organ, chemotherapy travels through the blood stream to reach cancer cells everywhere, especially in the bone marrow.
l High cure/control rates: it is highly effective in destroying abnormal cells, enabling long-term remission

.
2.Combination therapy : it is often paired with radiation ,stem cell transplant or targeted agents to boost efficacy.
l Phased approach: chemotherapy is delivered in cycles : induction(rapidly killing cells to achieve remission) , consolidation (eliminating remaining cells ) and maintenance (preventing recurrence)

Importance of targeted treatment in blood cancer
l Precision and specificity:These drugs target specific genetic mutations, proteins or pathways that cause cancer cells to grow and survive,sparing mostly healthy cells.
l Reduced side effects: By focusing on cancer cell weakness, they often cause less damage to healthy tissues compared to conventional chemotherapy.
2. improved forebeareance consequence: Targeted therapies can efficausly treat cancer that can relapsed or become resistant to traditional chemotherapy.
Both treatments are essential to the modern, personalized management of blood cancers, often used in tandem to maximize survival chances.

WHAT IS AZADIN 100 MG?
azadin 100 mg injection is a prescription cancer medication containing Azacitidine, used to treat myelodysplastic syndromes (MDS) ,acute myeloid leukaemia (AML) and chronic myleomonocytic leukaemia (CMML) . it works by killing or inhibiting the growth of abnormal blood/one marrow cells and is typically administered by a healthcare professional.
Key details:
l Indication: treats specific blood and bone marrow cancers
l Administration: given by subcutaneous injection or intravenous infusion.
l Storage: requires refrigeration
l Mechanism: a nucleoside metabolic inhibitor that acts as a chemotherapy agent.
This medication is often used when patient is not eligible for a stem cell transplantation. It is essential to consult a doctor ,as it is a potent, toxic and highly specalized chemotherapy drug.

WHAT ARE THE MEDICAL USES OF AZADIN 100 MG VIAL?
Azadin 100mg vial is an anti neoplastic (anti cancer) chemotherapy medication used to treat blood disorders and cancers, specifically myelodysplastic syndromes (MDS) ,chronic myleodyplastic leukemia (CMML) and acute myleiod leukemia (AML). it works by killing or stopping the growth of abnormal cancer cells in bone marrow.

Following are the medical uses of azadin 100 mg vial are :

1. Treatment of Myelodysplastic syndrome (MDS)
Aazidin is an anti-metabolic medication used in the treatment of myelodysplastic syndromes (MDS), including immediate -2 and high-risk cases, as well as chronic myelomonocytic leukemia (CMML) and acute myeloid leukaemia (AML) . it wors by inhibiting cancer cell growth and promoting normal blood cell production in the bone marrow.
l Administration: it is administered by a healthcare professional ,usually via subcutaneous injection or intravenous infusion.
l Treatment approach: treatment involves specific cycles, where the frequency and duration are determined by an oncologist based on patient responses and tolreabilty.
l Common side effect: these include nausea, vomiting ,injection site reactions, fever ,constipation ,diarrhea and cytopennias
l Monitoring: Regular blood test are required to monitor blood counts, liver and kidney functions.
l Precautions: patients should avoid alcohol, stay hydrated and report any severe side effects such as persistent infections or bleeding.

2. Treatment of acute myeloid lukemia (AML) in certain patients
Azadin (containing the active ingredient Azacitidine ) is a chemotherapy medication used for the treatment of certain adults with Acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy or homeopathic stem cell transplantation. It is particularly indicated for patients with 20-30% blasts and multi-lineage dysplasia.
l Indications: specifically approved for AML high-intensity curative treatments. It is also used for meylodysplastic syndrome (MDS) and chronic meylomonocytic leukaemia(CMML).
l Mechanism of action: As a hypomethylating agents, it works by inhibiting DNA methyltransferase ,which helps reactivate tumor-suppressor genes and stops the growth of cancer cells.
l Administration: it is administered by a healthcare professional, usually via subcutaneous injection into the thigh, abdomen, or upper arm.
l Common side effect:
1. Hematological: low white blood cell count (neutropenia) ,low platelet count (thrombocytopenia), and low red blood cell count (anemia).
2. Gastrointestinal: Nausea, vomiting, diarrhea, and constipation.
3. Other: injection site reactions (pain,redness) ,fever, fatigue and dizziness.
Treatment with Azadin should only be initiated and monitored under the supervision of a qualified physician experienced in the use of chemotherapeutic agents.

3 Managing bone marrow disorders
Azadin is a crucial medication in the management of specific, high-risk bone marrow disorders. It works as a hypomethylating agent that helps restore normal blood cell production and induces the death of abnormal cancer cells in the marrow.
l Indication: it is approved for myelodysplastic syndrome( MDS) ,chronic myelomonocytic leukemia (CMML) , and Acute Myeloid Leukemia (AML) .

l Administration: it is administered via subcutaneous injections or intravenous infusion, typically on a 7-day cycle every 4 weeks . an oral form (ONUREG) is used for continued remission in AML .
l Efficacy: studies have shown it improves overall survival and can delay disease progression in higher -risk MDS patients compared to conventional care.
l Mechanism of action: it is a pyrimidine nucleoside analog that ,when incorporated into DNA, inhibits DNA methyltransferase,allowing for the potential reactivation of genes that regulate differentiation and maturation of hematopoietic cells.
It is important to receive regular monitoring for infections and blood counts, and for healthcare providers to manage the potential for severe myelosuppression.

Conclusion: Azadin 100mg injection (containing Azacitidine ) is an anti neoplastic medication primary used to treat adults with blood and bone marrow disorders ,specifically Myelodysplastic leukemia (CMML) and acute myloid leukemia (AML) .it is a crucial, high-potency and often life-saving therapeutic option for patients ineligible for stem cell transplant ,working by inhibiting DNA methyltransferase to induce cell death in cancerous cell and promote normal blood cell production.

FREQUENTLY ASKED QUESTIONS (FAQ):
QUESTION: HOW LONG DOES AZADIN TREATMENT LAST?
Azadin treatment is typically administered in 28 -day cycles, with the medication taken for 7 consecutive days or 14 days within each cycle.

QUESTION: IS AZADIN A CHEMOTHERAPY DRUG?
Yes, Azadin is a prescription chemotherapy drug used in the treatment of specific blood and bone marrow cancers. It is classified as anti metabolite, which at as a hypomethylating agent to stop cancer cells from growing.

QUESTION: CAN AZADIN CURE BLOOD CANCER?
Azadin is a chemotherapy medication used to treat certain types of blood and bone marrow cancers, but it is not considered a universal cure for all blood cancers. It is a potent drug that works by interfering with the growth of cancer cells, which kills them off and allows normal blood cells to grow.

QUESTION: WHAT PRECAUTIONS SHOULD Patients FOLLOW DURING TREATMENT?
l It must be administered under the supervision of a healthcare professional, usually via subcutaneous injection or intravenous infusion
l The drug can be significantly lower white blood counts ,increasing the risk of infections. Avoid crowd places and people who are sick.
l This medication can cause serious birth defects. It is contraindicated during pregnancy and breastfeeding.
l Inform your doctor if you have existing liver or kidney disease, as dose adjustment may be necessary.

REFRENCES:

1.https://www.netmeds.com/product/azadine-100mg-injection-1-s-lui7y3-8352685

2.https://macariushealth.com/products/oncology-cancer-care/azadine-100mg-injection-100mg/

3.https://www.practo.com/medicine-info/azadine-100-mg-injection

4.https://www.medkart.in/order-medicine/azadine-injection?srsltid=AfmBOoo6tJ_bc1hHqKtQUAx64ROgG23wu_WC7J-tX6hqyn0mPxytqduB


 Read more “EVERYTHING YOU NEED TO KNOW ABOUT AZADIN 100ML VIAL”

Posted on:

WHY INFLUVAC VACCINATION IS IMPORTANT FOR FLU PREVENTION?

à

 

Posted on:

PNEUMONOVAX 23 PFS:WHO SHOULD GET IT AND WHY IT MATTERS

  1. Whys

 

Pneumonovax 23 is a vaccine designed to prevent pneumococcal infections, such as pneumonia, meningitis, and bacteremia, caused by 23 different strains of streptococcus pneumonia bacteria. This PFS(pre-filled syringe) is a convenient, sterile ,ready to use liquid format for administration.

Pneumonovax 23 is a vital vaccine that protects against 23 strains of streptococcus pneumonia bacteria, which cause severe,sometimes fatal infections like pneumonia, meningitis, and bloodstream infections. It is critical for adults 65 plus ,smokers ,and individuals with chronic hospitalization and severe infections.

 

HOW IMPORTANT DOES PNEUMNOVAX 23 PFS VACCINE FOR ADULTS?

Pneumonovax 23 (PPSV23) is a crucial vaccine for adults aged 50 plus and those with high -risk conditions, protecting against 23 types of pneumonia causing bacteria. It significantly reduces the risk of invasive pneumococcal disease and pneumonia ,lowering hospitalization and morality ,particularly in older adults and individuals with degenerative illness.

 

Target group: recommended for adults 65 plus ,adults 19-64 with chronic conditions (e.g asthma, COPD,diabetes, heart disease) ,smokers and immune compromised individuals.

Protection: covers 23 common streptococcus pneumonia e stereotypes responsible for over 90% of invasive disease.

Administration: typically a single intramuscular injection ,with a booster sometimes recommended after 5 years for high-risk individuals

Effectiveness: studies indicate an overall efficacy of 60-70% in preventing invasive disease.

Side effects: common reactions include soreness at the injection site, fever or rash.

 

WHAT IS PNEUMNOVAX 23?

Pneumococcal polysachride  vaccine, sold under the brand name pneumnovax 23 ,is a pneumnococal vaccine that is used for the prevention of pneumococcal disease caused by the 23 stereotype of streptococcus pneumoniae contained in the vaccine as capsular polysachrides.  The polysachrides agents were added to induce type-specific antibodies that enhance phagocytes and killing of streptococcus pneumonia e bacteria by phagocyte immune cells.

Pneumovax 23 is manufactured by Merck sharp &Dohme corp..,a subsidiary of Merck &co ,inc . it is a vaccine designed to protect against infections caused by streptococcus  pneumoniae bacteria , including pneumonia and meningitis. The product is often distributed as a pre -filled syringe .

Key manufacture & Information

Manufacturer: Merck Sharp & Dohme corp. 

Alternative name: Merck Sharp & Dhome BV (often used in international contexts) .

Manufacturing site: west point ,Pennsylvania,USA

Distributor/Marketer :  MSD pharmaceuticals pvt ltd. (india)

Format: As of April 2023, the manufacturer supplies PNUMOVAX 23 primarily as a 10-pack of pre -filled single-dose Luer -lok syringes.

The vaccine is indicated for individuals 2 years of age and older, with a focus on adults 50 and older or those with high risk conditions.

 

WHAT DISEASES DOES PNEUMONOVAX 23 PREVENT?

Diseases that are prevented by PNEMONOVAX 23 are :

PNEUMONOCOCAL PNEUMONIA

Pneumnovax 23 (PPSV23) helps prevent pneumococcal pneumonia and other serious infections caused by 23 common strains of streptococcus pneumonia bacteria.it is highly recommended by adults up to 65 age, individuals aged 2 plus with high -risk conditions and smokers. It protects against 23 strains of bacteria, reducing the risk of severe disease and hospitalization. it is effective at preventing pneumococcal pneumonia, particularly in reducing morality for high-risk individuals and nursing home residents.

 

BACTEREMIA (BLOODSTREAM INFECTION) 

Pneumococcal vaccines (PCV13, PPSV23) are highly pneumococcal disease, including bacteremia, (bloodstream infection ) and pneumococcal pneumonia ,by inducing antibodies that target specific stereotypes of streptococcus pneumoniae.  Studies shown that vaccines can be 78.5% effective in preventing type-specific pneumococcal pneumonia and bacteremia.  It works by stimulating antibodies that block the bacteria from invading the blood or causing pneumonia.

MENINGITIS

Pneumonia l cocal vaccines (PCV13, PCV15, PCV20 and PCV23) are the primary, highly effective method to prevent both pneumococcal meningitis and pneumococcal pneumonia. These vaccines protect against various strains of streptococcus pneumonia  bacteria that can cause both invasive diseases . these vaccines target the most common harmful strain . since the year  2000 , these vaccines have saved over 1.6 million lives and significantly reduce the incidence of morality  from pneumococcal disease.

 

OTHER INVASIVE PNEUMOCOCCAL DISEASES

Invasive pneumococcal diseases (IPD) including bacteria , septicemia and meningitis- are severe infections caused by streptococcus pneumonia that are effectively prevented by pneumococcal conjugate vaccines (PCV13, PCV15, PCV20) and the polysachride vaccine (PPSV23) ,which also protect against pneumococcal pneumonia .it reduces the overall burden of disease.

 

HOW IS PNEUMNOVAX 23 ADMINISTERED?

Pneumnovax works by each integrating the immune system to produce antibodies against 23 common types of streptococcus pneumoniae bacteria, protecting against invasive diseases like pneumonia and meningitis. It is a  polysachride vaccine that uses purified sugar coatings from the bacteria to trigger an immune response without causing disease.

Pneumnovax 23 administrated by the following ways:

STIMULATE  IMMUNE RESPONSE

Pneumonovx 23 (PPSV23) stimulate the immune response by exposing it to 23 different purified capsular polysaccharide antigens from the most common and invasive streptococcus pneumonia  bacteria. It is designed to trigger a T-cell-independent immune response .primarily in adults aged 50 and other high risk individuals.

 

PRODUCTION  OF PROTECTIVE ANTIBODIES

Pneumonovax 23 (PPSV23) is a 23- variant pneumococcal polysachride vaccine designed to induce type-specific antibodies that heighten optimization ,phagocytes . proactive antibody levels generally develop within 2 to 3 weeks after vaccination. More than 80% of healthy adults develop antibodies against the stereotype in the vaccine . studies show a 5.4 -fold average increase in antibody levels across different stereotypes.  The vaccine is 60% to 70% effective in preventing invasive pneumococcal disease (IPD) in healthy adults.

 

WHAT ARE THE  POSSIBLE SIDE EFFECTS OF PNEUMNOVAX 23 ?

Pneumounovax 23 commonly causes mild, short term side effects ,primarily injection site reactions  like pain, swelling and redness , which may occur in over 75% of patients . other common side effects include headache, fatigue ,muscle pain ,fever and reduced appetite ,generally resolving within 1-2 days.

 

Common side effects:

Injection site reactions: pain/soreness /tenderness (60%-70%) ,swelling/induration (20%-40%) and redness (16%-35%)

Systematic reactions: headache (17%-18%),fatigue /asthenia(13%-18%)

General:  fever (less than 10%)

 

Less common side effects

Local: intense swelling,  ‘’cellulitis-like’’ reactions or hard lumps at the injection site.

Systematic: chills, joint pain ,nausea ,vomiting or rash

Rare :severe allergic reactions or in very cases, Guillain- Barre syndrome.

 

CONCLUSION: pneumonovax 23 (PPSV23) is a highly effective ,safe vaccine for preventing invasive pneumococcal disease (IPD) caused by 23 stereotypes in adults >65 and high-risk individuals . it offers moderate protection against pneumonia and reduces hospitalization ,though its effectiveness may decrease with age and it is not recommended for children under 2.

 

FREQUENTLY ASKED QUESTIONS: 

QUESTION:  HOW LONG DOES PNEUMONOVAX 23  PROTECTION LAST?

Pneumnovax 23 typically provides protection for about 4 to 7 years in adults with antibody levels decline afterward . while some protection may last longer, a booster is often recommended every 5 years for high-risk individuals. Protection begins 2 to 3 weeks after vaccination .

QUESTION: CAN PNEUMNOVAX 23 PREVENT VIRAL PNEUMONIA?

Pneumnovax does not directly prevent viral pneumonia .it specifically protects against 23 types of bacteria that cause bacterial pneumonia, meningitis and bloodstream infections. It is primarily used for adults 65 plus and high -risk individuals . however it can prevent secondary bacterial infections that often occur after a viral infection.

QUESTION: CAN PNEUMNOVAX 23 IS MANDATORY FOR ELDERLY INDIVIDUALS ?

Pneumnovax 23 is strongly recommended for all adults aged 65 years and older by major health organizations , including centre for disease control and prevention (CDC) . it is consider a crucial preventive health measure for elderly people to protect severe infections caused by streptococcus pneumococci bacteria , such as pneumonia, meningitis and bloodstream infections.

REFRENCES

1. https://www.nhs.uk/vaccinations/pneumococcal-vaccine/

2.https://www.apollopharmacy.in/medicine/pneumovax-vaccines-23-0-5ml?srsltid=AfmBOopP0KfiHXcID6lvvhdwPqAeeOvCAqlEGq4Lcdksx4_yOqO-HWIU

3.https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html

4.https://www.news-medical.net/drugs/Pneumovax-23.aspx

 

 

 

 

 

Add to cart